A DNA-Changing Therapy for Duchenne Muscular Dystrophy

Researchers have identified a way of changing parts of DNA sequencing to be used as a treatment for genetic diseases. The CRISPR/Cas9 therapy (or clustered regularly interspaced short palindromic repeats) is a new method of genome editing which can be used in the treatment of Duchenne muscular dystrophy. CRISPR works by mimicking bacteria’s way of protecting itself when attacked by viral infections by capturing pieces of the virus’s DNA and inserting into its own DNA. When trialed on mouse models of Duchenne muscular dystrophy, CRISPR/Cas9 reported the reversal of some symptoms associated with Duchenne MD.

Source : MD NEWS